Ivantis Secures $27,000,000 Series B Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9f60c94a-68a9-4e31-9a18-67b09bd667da&Preview=1 -
Date
2/1/2013 -
Company Name
Ivantis -
Mailing Address
13766 Alton Parkway Irvine, CA 92618 -
Company Description
The company provides medical devices for the treatment of glaucoma. -
Website
http://www.ivantisinc.com -
Transaction Type
Venture Equity -
Transaction Amount
$27,000,000 -
Transaction Round
Series B -
Proceeds Purposes
These funds will be used to support four randomized, prospective, controlled multi-center trials at various stages around the world, including the ongoing United States trial. -
M&A Terms
-
Venture Investor
Ascension Health Ventures -
Venture Investor
New Enterprise Associates -
Venture Investor
Delphi Ventures -
Venture Investor
Undisclosed
